Observational Study of Nivolumab Monotherapy or in Combination With Ipilimumab in Participants With Advanced Melanoma and in Participants With Adjuvant Nivolumab Therapy
Clinical trial NCT02990611 · COMPLETED
Trial details
- NCT number
- NCT02990611
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-12-06
- Primary completion
- 2025-06-20
- Enrollment
- 1087
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.